Editors' ChoiceCancer Targeting an “undruggable” protein Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA See allHide authors and affiliations Science Signaling 08 Aug 2017:Vol. 10, Issue 491, eaao5809DOI: 10.1126/scisignal.aao5809 Leslie K. Ferrarelli , AAAS, Washington, DC 20005, USAFind this author on Google Scholar Find this author on PubMed Search for this author on this site Article Info & Metrics eLetters Article Information vol. 10 no. 491 DOI: https://doi.org/10.1126/scisignal.aao5809 Published By: Science Signaling Print ISSN: 1945-0877 Online ISSN: 1937-9145 History: . Copyright & Usage: Copyright © 2017, American Association for the Advancement of Science Author Information Leslie K. FerrarelliScience Signaling, AAAS, Washington, DC 20005, USA Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: August 2017 to January 2021 AbstractFullPdf Aug 201730899040 Sep 201752320 Oct 201735240 Nov 201732180 Dec 20172160 Jan 201830150 Feb 201823140 Mar 20182790 Apr 201817150 May 201823100 Jun 20181060 Jul 2018870 Aug 20180180 Sep 20180210 Oct 20180160 Nov 20180140 Dec 20180430 Jan 20192260 Feb 20192180 Mar 20192180 Apr 20190140 May 20192221 Jun 20192300 Jul 20190201 Aug 20190130 Sep 20192100 Oct 2019190 Nov 2019180 Dec 20192180 Jan 20200210 Feb 2020070 Mar 20200150 Apr 20200110 May 2020150 Jun 2020090 Jul 20200110 Aug 2020190 Sep 20202140 Oct 20200180 Nov 20200130 Dec 20204120 Jan 2021490 View Full Text
Targeting an “undruggable” protein By Leslie K. Ferrarelli Science Signaling08 Aug 2017 Blocking an interaction with the RNA-binding protein NEFLE or the kinase CAMKIIγ might provide new ways of inhibiting c-Myc in cancers.
Targeting an “undruggable” protein By Leslie K. Ferrarelli Science Signaling08 Aug 2017 Blocking an interaction with the RNA-binding protein NEFLE or the kinase CAMKIIγ might provide new ways of inhibiting c-Myc in cancers.